For Research Use Only. DSIP is intended exclusively for in vitro and preclinical research. It is not approved for human use, is not a drug, and should never be administered to humans or to animals outside of an authorized research protocol.
What Is the HPA Axis?
The hypothalamic-pituitary-adrenal (HPA) axis is the integrated neuroendocrine system that mediates the stress response in mammals. The system involves three main components: the hypothalamus (which releases corticotropin-releasing hormone, or CRH), the anterior pituitary (which releases adrenocorticotropic hormone, or ACTH), and the adrenal cortex (which produces glucocorticoid hormones such as cortisol in humans or corticosterone in rodents).
The HPA axis is activated by stress signals and produces a coordinated response involving the release of CRH from the hypothalamus, which stimulates ACTH release from the pituitary, which in turn stimulates glucocorticoid release from the adrenal cortex. The resulting elevated glucocorticoid levels mediate many of the biological effects of stress responses in research models.
The HPA axis is regulated by negative feedback, with elevated glucocorticoid levels suppressing further CRH and ACTH release through feedback signals to the hypothalamus and pituitary. This feedback regulation maintains the integrity of the stress response system and prevents excessive activation under normal conditions.
The HPA axis is one of the most studied neuroendocrine systems in research because of its central role in stress biology and its connections to multiple research areas including aging, disease research, behavioral biology, and various other topics.
DSIP and CRH Modulation
Corticotropin-releasing hormone (CRH) is the initiating signal in the HPA axis cascade, released from hypothalamic neurons in response to stress signals. DSIP has been characterized for effects on CRH release in research models, with the published findings providing initial evidence on DSIP modulation of the HPA axis at this initiating level.
The mechanism by which DSIP affects CRH release is still being characterized in research, but the published findings support effects that are consistent with DSIP acting as a modulator of stress response biology in research models. The hypothalamic expression of DSIP discussed in our companion article on DSIP discovery research provides the anatomical basis for this potential modulatory function.
The integration of DSIP effects on CRH with the broader sleep biology of the peptide is one of the conceptually interesting aspects of DSIP research. Sleep and stress are connected biological systems, and DSIP's dual effects on both systems make it a useful research tool for studying their integrated regulation.
DSIP and ACTH Release
Adrenocorticotropic hormone (ACTH) is released from anterior pituitary corticotrophs in response to CRH stimulation, providing the second step in the HPA axis cascade. DSIP has been characterized for effects on ACTH release in research models, complementing the CRH effects discussed above.
The published research on DSIP and ACTH includes effects in research animals under various experimental conditions. The findings generally support modulation of ACTH release by DSIP in research models, although the specific magnitudes and conditions vary across studies.
The pituitary expression of DSIP provides the anatomical basis for direct effects on pituitary corticotrophs in addition to the indirect effects mediated through CRH modulation. The combined direct and indirect effects on ACTH release contribute to the broader DSIP effects on the HPA axis in research models.
DSIP and Cortisol/Corticosterone
The downstream effects of DSIP on glucocorticoid release have been characterized in research models. Cortisol is the major glucocorticoid in humans and some other species, while corticosterone is the major glucocorticoid in rodents and is the form most commonly measured in rodent research models.
The published findings on DSIP and glucocorticoid release support modulation of these stress hormones in research models, consistent with the upstream effects on CRH and ACTH. The specific magnitudes and conditions of the glucocorticoid effects depend on the experimental design and on the research animal model used.
The integration of DSIP effects across all three levels of the HPA axis (CRH, ACTH, and glucocorticoids) provides a comprehensive picture of how the peptide modulates the stress response system. The convergence of evidence at multiple levels supports the conclusion that DSIP is a real modulator of HPA axis biology in research models.
Sleep-Stress Connection
The connection between sleep and stress biology is one of the more interesting aspects of DSIP research. Both sleep and stress are regulated by overlapping neuroendocrine systems, and many neuropeptides that affect one system also affect the other. DSIP's dual effects on sleep architecture (discussed in our companion article on DSIP sleep research) and on the HPA axis make it a particularly interesting research tool for studying the integrated biology of sleep and stress.
The bidirectional relationship between sleep and stress is well established in research literature. Stress disrupts sleep architecture, while sleep disruption activates the HPA axis. The integrated regulation of these two systems involves multiple molecular components, with DSIP being one specific example of a peptide that affects both.
Research applications of DSIP that focus on the sleep-stress connection take advantage of the dual effects of the peptide. Studies that examine how interventions affect both sleep and stress can use DSIP as a research tool for probing the integrated biology of these systems.